These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912 [TBL] [Abstract][Full Text] [Related]
45. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104 [TBL] [Abstract][Full Text] [Related]
50. To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPI [corrected]. Leontiadis GI; Howden CW Am J Gastroenterol; 2006 Sep; 101(9):2000-2. PubMed ID: 16968505 [TBL] [Abstract][Full Text] [Related]
51. Specifics of Helicobacter pylori infection/NSAID effects in the elderly. Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236 [TBL] [Abstract][Full Text] [Related]
52. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805 [TBL] [Abstract][Full Text] [Related]
53. Non-steroidal anti-inflammatory drugs and proton-pump inhibitors vs. cyclo-oxygenase-2 selective inhibitors in reducing the risk of recurrent ulcer bleeding in patients with arthritis. Chan FK Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():5-6, 21-4. PubMed ID: 15755266 [No Abstract] [Full Text] [Related]
54. Drug treatment of non-variceal upper gastrointestinal bleeding. Langman MJ Baillieres Best Pract Res Clin Gastroenterol; 2000 Jun; 14(3):357-64. PubMed ID: 10952802 [TBL] [Abstract][Full Text] [Related]
55. Recurrent ulcer bleeding: is intravenous omeprazole the solution? Nehme O; Barkin JS Am J Gastroenterol; 2001 Feb; 96(2):594-5. PubMed ID: 11232716 [No Abstract] [Full Text] [Related]
56. Proton pump inhibitors. Barry A Ir Med J; 1994; 87(5):134. PubMed ID: 7960649 [No Abstract] [Full Text] [Related]
57. High or low doses of PPIs for patients with peptic ulcer bleeding? Lin HJ Arch Intern Med; 2010 Oct; 170(18):1699-700; author reply 1700. PubMed ID: 20937935 [No Abstract] [Full Text] [Related]
58. [New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding]. Calvet X Gastroenterol Hepatol; 2010 May; 33 Suppl 1():11-4. PubMed ID: 20728784 [TBL] [Abstract][Full Text] [Related]
59. High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence. Calvet X; Barkun A; Bardou M; Sung J; Kuipers EJ Arch Intern Med; 2010 Oct; 170(18):1698-9; author reply 1700. PubMed ID: 20937933 [No Abstract] [Full Text] [Related]